Matches in Wikidata for { <http://www.wikidata.org/entity/Q94146317> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q94146317 description "article scientifique publié en 2018" @default.
- Q94146317 description "wetenschappelijk artikel" @default.
- Q94146317 description "наукова стаття" @default.
- Q94146317 name "ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS" @default.
- Q94146317 name "ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS" @default.
- Q94146317 type Item @default.
- Q94146317 label "ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS" @default.
- Q94146317 label "ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS" @default.
- Q94146317 prefLabel "ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS" @default.
- Q94146317 prefLabel "ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS" @default.
- Q94146317 P1433 Q94146317-1B5D8344-2BAC-4273-9CD3-DEC93A20F89F @default.
- Q94146317 P1476 Q94146317-C56E964E-39F3-4C6D-890F-0E61F1B1A8FA @default.
- Q94146317 P2093 Q94146317-2DBA517C-D57A-4EF7-82C1-B5F58341CC5D @default.
- Q94146317 P2093 Q94146317-522FDF40-2B12-45D3-AD0D-E12539AF3F22 @default.
- Q94146317 P2093 Q94146317-64A81FD6-1282-405B-9AFA-412A585A4659 @default.
- Q94146317 P2093 Q94146317-6E1ABFB5-3E3D-4874-A904-45855A19A18B @default.
- Q94146317 P2093 Q94146317-72651781-3587-479E-9581-73809D2A436E @default.
- Q94146317 P2093 Q94146317-731A3003-6A98-4A6F-ADEF-E63069C72D49 @default.
- Q94146317 P2093 Q94146317-76C739D1-6772-4A25-9E8B-56789C710BFC @default.
- Q94146317 P2093 Q94146317-77E77D6E-8C63-45A7-BE5A-A419FEF13C73 @default.
- Q94146317 P2093 Q94146317-9475F509-4975-4252-9F7A-474A403AF076 @default.
- Q94146317 P2093 Q94146317-9CA85708-E442-4919-A421-4EE3B01FCA6D @default.
- Q94146317 P2093 Q94146317-9E47FF18-64E0-45AE-B9E7-EB57E8C3C9B5 @default.
- Q94146317 P2093 Q94146317-A2A6DF8E-27A5-43EE-932B-0EB5C1CA58FF @default.
- Q94146317 P2093 Q94146317-A3C5F4B5-8419-4EEF-A4B2-B19C2E170AA5 @default.
- Q94146317 P2093 Q94146317-BBD17F48-B3CD-4046-9851-0F09D25D8A91 @default.
- Q94146317 P2093 Q94146317-C9B58E08-A5A2-4C12-8CAB-72C6F4BA6613 @default.
- Q94146317 P2093 Q94146317-D559290A-BFE0-4178-9F7C-6B4A4F07BB7A @default.
- Q94146317 P2093 Q94146317-D72118E3-83A6-48D8-84F5-AF60A31D1021 @default.
- Q94146317 P2093 Q94146317-DB8C0C26-5355-4CB9-AC05-A8A5E31E2FAC @default.
- Q94146317 P2093 Q94146317-E65BCE1F-6E2C-4AB5-B929-AE5354A50118 @default.
- Q94146317 P2093 Q94146317-EB53AB6B-C92A-44AC-A12D-3AEE581333F9 @default.
- Q94146317 P2093 Q94146317-FFD71D12-D7EB-487D-939F-93CECA966E38 @default.
- Q94146317 P304 Q94146317-E0501528-21F4-4194-900C-AAF862C72B00 @default.
- Q94146317 P31 Q94146317-5670AFCE-D4EF-422B-97B5-CE5358413152 @default.
- Q94146317 P356 Q94146317-39806850-2808-4C00-BDEC-6ADC6D4CA1C7 @default.
- Q94146317 P433 Q94146317-23107A00-7C2D-4291-9095-0914C365CD60 @default.
- Q94146317 P478 Q94146317-8F2A89FE-7D18-4D13-823B-D481145307F7 @default.
- Q94146317 P50 Q94146317-63D17FA1-7C32-4C2B-976D-CAB666D7F3FB @default.
- Q94146317 P577 Q94146317-F9F87740-D8C0-49C1-B93A-AD73AD9CA666 @default.
- Q94146317 P921 Q94146317-5453348F-D0AC-42E6-9D42-4BA5988B34BA @default.
- Q94146317 P921 Q94146317-8A863A83-30DF-490C-8F9B-49A2836F9820 @default.
- Q94146317 P921 Q94146317-A042BD1D-577D-47A6-98CB-58189311E4E0 @default.
- Q94146317 P932 Q94146317-4E453ADD-FEF7-419D-ABD2-91BA46E23C01 @default.
- Q94146317 P356 NOY148.047 @default.
- Q94146317 P1433 Q15724471 @default.
- Q94146317 P1476 "ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS" @default.
- Q94146317 P2093 "David Peereboom" @default.
- Q94146317 P2093 "David Tran" @default.
- Q94146317 P2093 "Fabio Iwamoto" @default.
- Q94146317 P2093 "Howard Colman" @default.
- Q94146317 P2093 "Jeffrey Raizer" @default.
- Q94146317 P2093 "Jihong Xu" @default.
- Q94146317 P2093 "Jimin Wu" @default.
- Q94146317 P2093 "Jing Wu" @default.
- Q94146317 P2093 "Karen Fink" @default.
- Q94146317 P2093 "Marc Chamberlain" @default.
- Q94146317 P2093 "Mark Gilbert" @default.
- Q94146317 P2093 "Marta Penas-Prado" @default.
- Q94146317 P2093 "Morris Groves" @default.
- Q94146317 P2093 "Nicholas Avgeropoulos" @default.
- Q94146317 P2093 "Pierre Giglio" @default.
- Q94146317 P2093 "Ryan Merrell" @default.
- Q94146317 P2093 "Terri Armstrong" @default.
- Q94146317 P2093 "Tobias Walbert" @default.
- Q94146317 P2093 "Vinay Puduvalli" @default.
- Q94146317 P2093 "W K Alfred Yung" @default.
- Q94146317 P2093 "Ying Yuan" @default.
- Q94146317 P304 "vi13-vi13" @default.
- Q94146317 P31 Q13442814 @default.
- Q94146317 P356 "10.1093/NEUONC/NOY148.047" @default.
- Q94146317 P433 "Suppl 6" @default.
- Q94146317 P478 "20" @default.
- Q94146317 P50 Q121436715 @default.
- Q94146317 P577 "2018-11-05T00:00:00Z" @default.
- Q94146317 P921 Q282142 @default.
- Q94146317 P921 Q413299 @default.
- Q94146317 P921 Q42824440 @default.
- Q94146317 P932 "6216165" @default.